Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia
Clinical trial NCT05932524 · UNKNOWN
Trial details
- NCT number
- NCT05932524
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2024-06-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.